These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17414651)

  • 1. What is the true place of blood pressure in cardiovascular risk management?
    McInnes GT
    J Hypertens; 2007 May; 25(5):925-8. PubMed ID: 17414651
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk: who should we treat, and how much should we stratify?
    Patel A
    Heart; 2009 May; 95(10):783-4. PubMed ID: 19131441
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of older hypertensive patients.
    Hedner T; Kjeldsen S; Oparil S; Narkiewics K
    Blood Press; 2008; 17(4):184-5. PubMed ID: 18932064
    [No Abstract]   [Full Text] [Related]  

  • 4. Are guidelines effectively guiding antihypertensive therapy?
    Vasan RS; Kannel WB
    Am J Cardiol; 2007 Jul; 100(1):143-4. PubMed ID: 17599457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 7. Going steady.
    Harv Heart Lett; 2010 Jun; 20(10):6. PubMed ID: 20589956
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk prediction in subjects with high-normal blood pressure.
    Schneider MP; Schmieder RE
    J Hypertens; 2009 Jun; 27(6):1126-8. PubMed ID: 19454903
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
    Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
    Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of recent trial results on cardiovascular risk management (Hatter Institute Cardiac Horizons series).
    Cardiovasc J Afr; 2008; 19(6):328-31. PubMed ID: 19104733
    [No Abstract]   [Full Text] [Related]  

  • 14. Arterial 'prehypertension': a useful concept for drug companies, useless for patients.
    Prescrire Int; 2007 Apr; 16(88):73-5. PubMed ID: 17460859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure lowering only or more? Has the jury reached its verdict?
    Julius S
    Am J Cardiol; 2007 Aug; 100(3A):32J-37J. PubMed ID: 17666196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

  • 17. Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.
    Qin X; Jackson R; Marshall R; Lee L; Cao W; Zhan S; Hu Y
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):96-101. PubMed ID: 19237999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid and blood pressure reduction for reduction of cardiovascular mortality].
    Heinzl S
    Med Monatsschr Pharm; 2003 Jun; 26(6):185. PubMed ID: 12840952
    [No Abstract]   [Full Text] [Related]  

  • 19. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.